{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T03:48:23Z","timestamp":1791776903671,"version":"4.3.4"},"reference-count":47,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T00:00:00Z","timestamp":1791676800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T00:00:00Z","timestamp":1791676800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100004431","name":"Fondation de France","doi-asserted-by":"publisher","award":["00131140\/WB\u20102022\u201044423"],"award-info":[{"award-number":["00131140\/WB\u20102022\u201044423"]}],"id":[{"id":"10.13039\/501100004431","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["advanced.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Adv Healthcare Materials"],"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Patient\u2010derived tumor organoids (PDOs) closely preserve the cellular heterogeneity, histopathology, and molecular features of the original tumors, making them powerful preclinical models. Antisense oligonucleotides (ASOs) are an emerging class of precision medicines that modulate gene expression at the RNA level with high target specificity, yet their application in organoid systems remains underexplored. Here, we adapted previously described protocols to establish a biobank of prostate cancer (PC) PDOs, achieving a high initial growth success rate (&gt;90%). Histological and molecular analyses confirmed the preservation of key tumor features. Using these models, we assessed several ASOs, with particular emphasis on OGX\u2010427 (Apatorsen), an ASO targeting heat shock protein 27 (HSP27) that has been evaluated in phase I\/II clinical trials. While OGX\u2010427 effectively suppressed HSP27 expression and inhibited cell growth in 2D cultures, its efficacy was markedly limited in 3D organoids, likely due to extracellular matrix and structural barriers. Removing Matrigel and applying single\u2010cell transfection overcame these barriers, achieving efficient ASO uptake, significant target protein downregulation, and robust, dose\u2010dependent inhibition of organoid growth. These findings underscore the utility of PDOs for evaluating ASO\u2010based therapies and their potential to accelerate precision oncology strategies for PC and other malignancies.<\/jats:p>","DOI":"10.1002\/adhm.202505251","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T03:40:48Z","timestamp":1791776448000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prostate Cancer Patient\u2010Derived Organoids (PDOs) as Functional Avatars for Antisense Oligonucleotide (ASO)\u2010Based Personalized Therapy"],"prefix":"10.1002","author":[{"given":"Thi Thom","family":"Tran","sequence":"first","affiliation":[{"name":"INSERM ERL U1326 CINaM CERIMED CNRS UMR 7325 Aix\u2010Marseille University Marseille France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thi Tu Uyen","family":"Phan","sequence":"additional","affiliation":[{"name":"INSERM ERL U1326 CINaM CERIMED CNRS UMR 7325 Aix\u2010Marseille University Marseille France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Baboudjian","sequence":"additional","affiliation":[{"name":"INSERM ERL U1326 CINaM CERIMED CNRS UMR 7325 Aix\u2010Marseille University Marseille France"},{"name":"Department of Urology Hospital Nord, AP\u2010HM Aix\u2010Marseille University Marseille France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quang Hieu","family":"Duong","sequence":"additional","affiliation":[{"name":"INSERM ERL U1326 CINaM CERIMED CNRS UMR 7325 Aix\u2010Marseille University Marseille France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Sousa","sequence":"additional","affiliation":[{"name":"INSERM ERL U1326 CINaM CERIMED CNRS UMR 7325 Aix\u2010Marseille University Marseille France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thi Thuy","family":"Le","sequence":"additional","affiliation":[{"name":"INSERM ERL U1326 CINaM CERIMED CNRS UMR 7325 Aix\u2010Marseille University Marseille France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Baylot","sequence":"additional","affiliation":[{"name":"INSERM ERL U1326 CINaM CERIMED CNRS UMR 7325 Aix\u2010Marseille University Marseille France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Giusiano","sequence":"additional","affiliation":[{"name":"INSERM ERL U1326 CINaM CERIMED CNRS UMR 7325 Aix\u2010Marseille University Marseille France"},{"name":"Laboratoire d'Anatomie et Cytologie Pathologiques, H\u00f4pital de la Timone, AP\u2010HM Marseille France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Daniel","sequence":"additional","affiliation":[{"name":"Laboratoire d'Anatomie et Cytologie Pathologiques, H\u00f4pital de la Timone, AP\u2010HM Marseille France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Brige","sequence":"additional","affiliation":[{"name":"European Center for Research in Medical Imaging (CERIMED) Aix\u2010Marseille University  Marseille France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Guillet","sequence":"additional","affiliation":[{"name":"European Center for Research in Medical Imaging (CERIMED) Aix\u2010Marseille University  Marseille France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrille","family":"Bastide","sequence":"additional","affiliation":[{"name":"Department of Urology Hospital Nord, AP\u2010HM Aix\u2010Marseille University Marseille France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Garrido","sequence":"additional","affiliation":[{"name":"University of Burgundy Europe, INSERM UMR 1231, HSP\u2010Pathies Centre for Translational and Molecular Medicine  Dijon France"},{"name":"University of Burgundy Europe Centre Georges\u2010Fran\u00e7ois Leclerc (CGFL)  Dijon France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ta\u00efeb","sequence":"additional","affiliation":[{"name":"INSERM ERL U1326 CINaM CERIMED CNRS UMR 7325 Aix\u2010Marseille University Marseille France"},{"name":"Department of Nuclear Medicine H\u00f4pital de la Timone, AP\u2010HM, Aix\u2010Marseille University Marseille France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1883-0371","authenticated-orcid":false,"given":"Thi Khanh","family":"Le","sequence":"additional","affiliation":[{"name":"INSERM ERL U1326 CINaM CERIMED CNRS UMR 7325 Aix\u2010Marseille University Marseille France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4383-4684","authenticated-orcid":false,"given":"Palma","family":"Rocchi","sequence":"additional","affiliation":[{"name":"INSERM ERL U1326 CINaM CERIMED CNRS UMR 7325 Aix\u2010Marseille University Marseille France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,10,11]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2024.04.010"},{"key":"e_1_2_11_4_1","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1001\/jamaoncol.2022.7762","article-title":"First\u2010Line Systemic Treatment Options for Metastatic Castration\u2010Sensitive Prostate Cancer","volume":"9","author":"Riaz I. B.","year":"2023","journal-title":"JAMA Oncology"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15205047"},{"key":"e_1_2_11_6_1","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/s42003-024-06121-9","article-title":"Between Hope and Reality: Treatment of Genetic Diseases Through Nucleic Acid\u2010Based Drugs","volume":"7","author":"Baylot V.","year":"2024","journal-title":"Communications Biology"},{"key":"e_1_2_11_7_1","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/s41467-021-21300-6","article-title":"Patient\u2010Derived Xenografts and Organoids Model Therapy Response in Prostate Cancer","volume":"12","author":"Karkampouna S.","year":"2021","journal-title":"Nature Communications"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.onano.2026.100300"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15071930"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2020.11.010"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aao2774"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/gastro\/goy040"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.762184"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.08.016"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11102743"},{"key":"e_1_2_11_16_1","doi-asserted-by":"crossref","DOI":"10.1172\/JCI169616","article-title":"Prostate Organoids: Emerging Experimental Tools for Translational Research","volume":"133","author":"Beshiri M.","year":"2023","journal-title":"Journal of Clinical Investigation"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04495-z"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/path.5698"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2016.006"},{"key":"e_1_2_11_20_1","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13046-026-03695-6","article-title":"HSP27 Functional Switch Drives Castration\u2010Resistant Prostate Cancer via mTOR Pathway Activation, Highlighting Promising Combination Therapies","volume":"45","author":"Duong Q. H.","year":"2026","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13046\u2010026\u201003826\u2010z"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-017-0553-x"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-018-0087-9"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-03-3998"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-1840"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2009.479"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2012.155"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.20469"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-021-02039-2"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2022.08.005"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14194773"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13050623"},{"key":"e_1_2_11_33_1","doi-asserted-by":"crossref","first-page":"7952","DOI":"10.1038\/s41598-018-26253-3","article-title":"Optimized Delivery of siRNA Into 3D Tumor Spheroid Cultures In Situ","volume":"8","author":"Morgan R. G.","year":"2018","journal-title":"Scientific Reports"},{"key":"e_1_2_11_34_1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00120-024-02285-8","article-title":"Palliative Chirurgie des metastasierten Prostatakarzinoms","volume":"63","author":"Heidenreich A.","year":"2024","journal-title":"Urologie"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/pros.24682"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25021093"},{"key":"e_1_2_11_37_1","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s13046-023-02801-2","article-title":"A Patient\u2010Derived Organoid\u2010Based Study Identified an ASO Targeting SNORD14E for Endometrial Cancer Through Reducing Aberrant FOXM1 Expression and \u03b2\u2010Catenin Nuclear Accumulation","volume":"42","author":"Chen X.","year":"2023","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2022.941528"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-08462-1"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceb.2016.07.003"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.3779"},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkw236"},{"key":"e_1_2_11_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2017.04.042"},{"key":"e_1_2_11_44_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-020-0075-7"},{"key":"e_1_2_11_45_1","doi-asserted-by":"publisher","DOI":"10.1089\/nat.2018.0727"},{"key":"e_1_2_11_46_1","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12091933"},{"key":"e_1_2_11_47_1","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202417363"},{"key":"e_1_2_11_48_1","doi-asserted-by":"publisher","DOI":"10.1293\/tox.2017-0060"}],"container-title":["Advanced Healthcare Materials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/advanced.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/adhm.202505251","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/advanced.onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/adhm.202505251","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/advanced.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/adhm.202505251","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T03:40:51Z","timestamp":1791776451000},"score":1,"resource":{"primary":{"URL":"https:\/\/advanced.onlinelibrary.wiley.com\/doi\/10.1002\/adhm.202505251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,11]]},"references-count":47,"alternative-id":["10.1002\/adhm.202505251"],"URL":"https:\/\/doi.org\/10.1002\/adhm.202505251","archive":["Portico"],"relation":{},"ISSN":["2192-2640","2192-2659"],"issn-type":[{"value":"2192-2640","type":"print"},{"value":"2192-2659","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,11]]},"assertion":[{"value":"2025-10-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e05251"}}